World's Best Scientists 2026 revealed!
Punnee Pitisuttithum

Punnee Pitisuttithum

Award Badge
Immunology
Thailand
2026

D-Index & Metrics

Immunology

D-Index
57
Citations
23213
World Ranking
3578
National Ranking
3

Research.com Recognitions

  • 2026 - Research.com Immunology in Thailand Leader Award
  • 2025 - Research.com Immunology in Thailand Leader Award

Overview

Punnee Pitisuttithum is affiliated with Mahidol University in Thailand and has contributed significantly to medical research, particularly in vaccine development and infectious diseases. Their body of work spans multiple intersecting fields such as Medicine, Immunology and Microbiology, with focused subfields including Infectious Diseases, Epidemiology, Immunology, Virology, and Health.

Their research covers a broad range of topics, notably SARS-CoV-2 and COVID-19 Research, HIV Research and Treatment, Vaccine Coverage and Hesitancy, HIV/AIDS Research and Interventions, Monoclonal and Polyclonal Antibodies Research, Cervical Cancer and HPV Research, and Hepatitis B Virus Studies.

Frequently publishing in several scientific venues, Punnee Pitisuttithum has appeared multiple times in:

  • Vaccine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • EClinicalMedicine
  • Expert Review of Vaccines

Collaborations with other researchers form a notable aspect of Pitisuttithum's work. Prominent co-authors include Sorachai Nitayaphan, Sandhya Vasan, Supachai Rerks-Ngarm, Viravarn Luvira, and Saranath Lawpoolsri.

Selected recent papers encompass a range of vaccine-related studies and immunological research including:

  • "Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer," 2021, published in Vaccines
  • "COVID-19 vaccine strategies must focus on severe disease and global equity," 2021, published in The Lancet
  • "A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future," 2021, published in Vaccine
  • "Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up," 2020, published in Papillomavirus Research
  • "Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial," 2022, published in EClinicalMedicine

Best Publications

  • Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

    Supachai Rerks-Ngarm;Punnee Pitisuttithum;Sorachai Nitayaphan;Jaranit Kaewkungwal

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner

  • A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

    Elmar A. Joura;Anna R. Giuliano;Ole-Erik Iversen;Celine Bouchard

  • Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

    Maria Rosario Capeding;Ngoc Huu Tran;Sri Rezeki S. Harun Hadinegoro;Hussain Imam Hj Muhammad Ismail

  • Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, Thailand

    Punnee Pitisuttithum;Peter Gilbert;Marc Gurwith;William Heyward

  • Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

    Melissa D. Simek;Wasima Rida;Frances H. Priddy;Pham Pung

  • Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2

    Arjen M Dondorp;Varunee Desakorn;Wirichada Pongtavornpinyo;Duangjai Sahassananda

  • Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination

    Nicole L. Yates;Nicole L. Yates;Hua Xin Liao;Hua Xin Liao;Youyi Fong;Allan DeCamp

  • Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family

    Mattia Bonsignori;Justin Pollara;M. Anthony Moody;Michael D. Alpert

  • Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

    Georgia D. Tomaras;Guido Ferrari;Xiaoying Shen;S. Munir Alam

  • Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines

    Amy W. Chung;Musie Ghebremichael;Hannah Robinson;Eric Brown

  • Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

    Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan

  • End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age

    X Castellsague;N Munoz;P Pitisuttithum;Daron G. Ferris

  • Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

    David C. Montefiori;Chitraporn Karnasuta;Ying Huang;Hasan Ahmed

  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    Dan H Barouch;Dan H Barouch;Frank L Tomaka;Frank Wegmann;Daniel J Stieh

  • Activity of posaconazole in the treatment of central nervous system fungal infections

    Punnee Pitisuttithum;Ricardo Negroni;John R. Graybill;Beatriz Bustamante

  • Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection

    Susan Zolla-Pazner;Allan DeCamp;Peter B. Gilbert;Constance Williams

  • COMPASS identifies T-cell subsets correlated with clinical outcomes

    Lin Lin;Greg Finak;Kevin Ushey;Chetan Seshadri

  • Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.

    Issam I. Raad;John R. Graybill;Ana Beatriz Bustamante;Oliver A. Cornely

  • Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.

    Merlin L Robb;Supachai Rerks-Ngarm;Sorachai Nitayaphan;Punnee Pitisuttithum

Frequent Co-Authors

Jerome H. Kim
Jerome H. Kim Walter Reed Army Institute of Research
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Sorachai Nitayaphan
Sorachai Nitayaphan Armed Forces Research Institute of Medical Science
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research
Georgia D. Tomaras
Georgia D. Tomaras Duke University
David C. Montefiori
David C. Montefiori Duke University
Barton F. Haynes
Barton F. Haynes Duke University
Hua-Xin Liao
Hua-Xin Liao Duke University
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
Guido Ferrari
Guido Ferrari Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career pathways in healthcare and research. Many professionals begin with foundational programs such as online BSN programs for non nurses, which offer accessible routes into nursing for individuals from varied backgrounds.

Specialization is key to advancing your career. For example, accelerating your studies through an accelerated NP program can prepare you to become a Nurse Practitioner in a shorter time frame, facilitating quicker entry into advanced clinical roles.

Certification adds another layer of expertise. Transitioning to roles like an acute care specialist often requires targeted qualifications such as acute care NP certification, which equips nurses with the skills needed in high-stakes medical environments.

Finally, understanding compensation trends is important for long-term planning. Resources detailing how much do DNP nurses make can provide insight into salary expectations across different states, helping graduates make informed career decisions.

Best Scientists Citing Punnee Pitisuttithum

Trending Scientists